Conectus
ALMS THERAPEUTICS

Picto Conectus
2017
Health (therapeutic & diagnosis)

ALMS THERAPEUTICS

ALMS THERAPEUTICS

Description:

  • New peptide drug candidates to treat patients with insulin-resistant type 2 diabetes.
  • Alms Therapeutics offers patients a much more flexible, effective treatment with fewer side effects.

At the origin of the project

  • Vincent MARION, Institut de Génétique Médicale de Strasbourg / University of Strasbourg, INSERM UMRS 1112, Federation of Translational Medicine of Strasbourg

Do you really want to remove this technology from your list ?
close